A genotoxic screen: Rapid analysis of cellular dose-response to a wide range of agents that either damage DNA or alter genome maintenance pathways

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 554, Issue 1-2, 2004, Pages 253-266

  Marple, Teresa ^a   Li, Han ^a   Hasty, Paul ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Anti cancer therapeutics; Chemotherapy; Dose response; Drug resistance; Hypersensitivity

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; ACETYLCYSTEINE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; APHIDICOLIN; CAMPTOTHECIN; CISPLATIN; DEMECOLCINE; DNA TOPOISOMERASE INHIBITOR; EBSELEN; ETHYLNITROSOUREA; ETOPOSIDE; HYDROXYUREA; MESYLIC ACID METHYL ESTER; MIMOSINE; MITOMYCIN; PARAQUAT; RUFOCROMOMYCIN; TIOGUANINE; TRICHOSTATIN A;

ANIMAL CELL; ARTICLE; CHROMATIN CONDENSATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG MECHANISM; EMBRYO CELL; GAMMA RADIATION; GENE MUTATION; GENETIC VARIABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TOXICITY TESTING; ULTRAVIOLET C RADIATION;

ALKYLATING AGENTS; ANIMALS; CELL LINE; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME INHIBITORS; GENOME; HELA CELLS; HUMANS; MICE;

EID: 4344582945     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.05.004     Document Type: Article

References (57)

1. E.C. Friedberg, G.C. Walker, W. Siede, DNA Repair and Mutagenesis, American Society of Microbiology, Washington, DC, 1995.
2. Wilson D.M. III, Sofinowski T.M., McNeill D.R. Repair mechanisms for oxidative DNA damage. Front. Biosci. 8:2003;d963-981
3. de Laat W.L., Jaspers N.G., Hoeijmakers J.H. Molecular mechanism of nucleotide excision repair. Genes Dev. 13:1999;768-785
4. Citterio E., Vermeulen W., Hoeijmakers J.H. Transcriptional healing. Cell. 101:2000;447-450
5. Sung P., Trujillo K.M., Van Komen S. Recombination factors of Saccharomyces cerevisiae. Mutat. Res. 451:2000;257-275
6. Lieber M.R., Ma Y., Pannicke U., Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat. Rev. Mol. Cell Biol. 4:2003;712-720
7. Thompson L.H., Schild D. The contribution of homologous recombination in preserving genome integrity in mammalian cells. Biochemistry. 81:1999;87-105
8. Kolodner R.D., Marsischky G.T. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev. 9:1999;89-96
9. Bachrati C.Z., Hickson I.D. RecQ helicases: suppressors of tumorigenesis and premature aging. Biochem. J. 374:2003;577-606
10. Duguet M. When helicase and topoisomerase meet. J. Cell Sci. 110(Pt 12):1997;1345-1350
11. Shcherbakova P.V., Bebenek K., Kunkel T.A. Functions of eukaryotic DNA polymerases. Sci. SAGE KE. 2003:2003;RE3
12. Greider C.W. Telomeres do D-loop-T-loop. Cell. 97:1999;419-422
13. Osborn A.J., Elledge S.J., Zou L. Checking on the fork: the DNA-replication stress-response pathway. Trends Cell Biol. 12:2002;509-516
14. Zhou B.B., Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature. 408:2000;433-439
15. Bree R.T., Stenson-Cox C., Grealy M., Byrnes L., Gorman A.M., Samali A. Cellular longevity: role of apoptosis and replicative senescence. Biogerontology. 3:2002;195-206
16. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849
17. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967
18. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature. 411:2001;366-374
19. Bolzan A.D., Bianchi M.S. Genotoxicity of streptonigrin: a review. Mutat. Res. 488:2001;25-37
20. Bus J.S., Aust S.D., Gibson J.E. Superoxide- and singlet oxygen-catalyzed lipid peroxidation as a possible mechanism for paraquat (methyl viologen) toxicity. Biochem. Biophys. Res. Commun. 58:1974;749-755
21. Cotgreave I.A. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv. Pharmacol. 38:1997;205-227
22. Nakamura Y., Feng Q., Kumagai T., Torikai K., Ohigashi H., Osawa T., Noguchi N., Niki E., Uchida K. Ebselen, a glutathione peroxidase mimetic seleno-organic compound, as a multifunctional antioxidant. Implication for inflammation-associated carcinogenesis. J. Biol. Chem. 277:2002;2687-2694
23. Vogel E.W., Nivard M.J., Ballering L.A., Bartsch H., Barbin A., Nair J., Comendador M.A., Sierra L.M., Aguirrezabalaga I., Tosal L., Ehrenberg L., Fuchs R.P., Janel-Bintz R., Maenhaut-Michel G., Montesano R., Hall J., Kang H., Miele M., Thomale J., Bender K., Engelbergs J., Rajewsky M.F. DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation. Mutat. Res. 353:1996;177-218
24. Sobol R.W., Wilson S.H. Mammalian DNA beta-polymerase in base excision repair of alkylation damage. Prog. Nucl. Acid Res. Mol. Biol. 68:2001;57-74
25. Engelward B.P., Weeda G., Wyatt M.D., Broekhof J.L., de Wit J., Donker I., Allan J.M., Gold B., Hoeijmakers J.H., Samson L.D. Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc. Natl. Acad. Sci. USA. 94:1997;13087-13092
26. Cabelof D.C., Guo Z., Raffoul J.J., Sobol R.W., Wilson S.H., Richardson A., Heydari A.R. Base excision repair deficiency caused by polymerase beta haploinsufficiency: accelerated DNA damage and increased mutational response to carcinogens. Cancer Res. 63:2003;5799-5807
27. Kat A., Thilly W.G., Fang W.H., Longley M.J., Li G.M., Modrich P. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA. 90:1993;6424-6428
28. Pegg A.E. Repair of O(6)-alkylguanine by alkyltransferases. Mutat. Res. 462:2000;83-100
29. Liu L., Hachey D.L., Valadez G., Williams K.M., Guengerich F.P., Loktionova N.A., Kanugula S., Pegg A.E. Characterization of a mutagenic DNA adduct formed from 1,2-dibromoethane by O6-alkylguanine-DNA alkyltransferase. J. Biol. Chem. 279:2004;4250-4259
30. Bessho T. Induction of DNA replication-mediated double strand breaks by psoralen DNA interstrand cross-links. J. Biol. Chem. 278:2003;5250-5254
31. Aloyz R., Xu Z.Y., Bello V., Bergeron J., Han F.Y., Yan Y., Malapetsa A., Alaoui-Jamali M.A., Duncan A.M., Panasci L. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD. Cancer Res. 62:2002;5457-5462
32. Yang X.L., Wang A.H. Structural studies of atom-specific anticancer drugs acting on DNA. Pharmacol. Ther. 83:1999;181-215
33. Wang J.C. DNA topoisomerases. Annu. Rev. Biochem. 65:1996;635-692
34. Chen A.Y., Liu L.F. DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol. 34:1994;191-218
35. Froelich-Ammon S.J., Osheroff N. Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J. Biol. Chem. 270:1995;21429-21432
36. Pommier Y. Diversity of DNA topoisomerases I and inhibitors. Biochemistry. 80:1998;255-270
37. Streltsov S.A. Action Models for the Antitumor Drug Camptothecin: Formation of Alkali- labile Complex with DNA and Inhibition of Human DNA Topoisomerase I. J. Biomol. Struct. Dyn. 20:2002;447-454
38. Staker B.L., Hjerrild K., Feese M.D., Behnke C.A., Burgin A.B. Jr., Stewart L. The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc. Natl. Acad. Sci. USA. 99:2002;15387-15392
39. Hertzberg R.P., Caranfa M.J., Hecht S.M. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry. 28:1989;4629-4638
40. Liu L.F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58:1989;351-375
41. Hande K.R. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer. 34:1998;1514-1521
42. Tanabe K., Ikegami Y., Ishida R., Andoh T. Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives. Cancer Res. 51:1991;4903-4908
43. Adachi N., Suzuki H., Iiizumi S., Koyama H. Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage. J. Biol. Chem. 278:2003;35897-35902
44. Meuth M. The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells. Exp. Cell. Res. 181:1989;305-316
45. Thomas D.C., Roberts J.D., Kunkel T.A. Heteroduplex repair in extracts of human HeLa cells. J. Biol. Chem. 266:1991;3744-3751
46. Goscin L.P., Byrnes J.J. DNA polymerase delta: one polypeptide, two activities. Biochemistry. 21:1982;2513-2518
47. Cleaver J.E. Specificity and completeness of inhibition of DNA repair by novobiocin and aphidicolin. Carcinogenesis. 3:1982;1171-1174
48. Alpan R.S., Pardee A.B. p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ. 7:1996;893-901
49. Wang G., Miskimins R., Miskimins W.K. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1). Exp. Cell. Res. 254:2000;64-71
50. Levina E.M., Kharitonova M.A., Rovensky Y.A., Vasiliev J.M. Cytoskeletal control of fibroblast length: experiments with linear strips of substrate. J. Cell. Sci. 114:2001;4335-4341
51. Balczon R., Varden C.E., Schroer T.A. Role for microtubules in centrosome doubling in Chinese hamster ovary cells. Cell. Motil. Cytoskeleton. 42:1999;60-72
52. Marks P.A., Richon V.M., Breslow R., Rifkind R.A. Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13:2001;477-483
53. Melton D.W., Konecki D.S., Brennand J., Caskey C.T. Structure, expression, and mutation of the hypoxanthine phosphoribosyltransferase gene. Proc. Natl. Acad. Sci. USA. 81:1984;2147-2151
54. Aladjem M.I., Spike B.T., Rodewald L.W., Hope T.J., Klemm M., Jaenisch R., Wahl G.M. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 8:1998;145-155
55. de las Alas M.M., Los G., Lin X., Kurdi-Haidar B., Manorek G., Howell S.B. Identification of transdominant-negative genetic suppressor elements derived from hMSH2 that mediate resistance to 6-thioguanine. Mol. Pharmacol. 62:2002;1198-1206
56. Abuin A., Zhang H., Bradley A. Genetic analysis of mouse embryonic stem cells bearing Msh3 and Msh2 single and compound mutations. Mol. Cell. Biol. 20:2000;149-157
57. Hurley L.H. DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer. 2:2002;188-200